Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: axial who wrote (9087)	3/23/2002 11:54:33 AM
From: Joe Krupa	Read Replies (1) \| Respond to of 14101

Hi Jim "I wonder what accounts for the "special treatment" DMX gets from HC?" I can only guess, but I'd say public visibility might have something to do with it. Hemosol makes much bigger headlines than DMX, and a significant HC leak would make the sub-text of those headlines. With DMX, I could just hear the conversation at HC: "Heck, nobody watches this thing anyway, let's see if we can do some favours for some people." (disclaimer: IMO only). If trading volume is an indicator of public visibility, take the following example. Here's the trading volume for the two days following both the DMX and HML, Health Canada news: HML 03/22/2002 - 699,338 03/21/2002 - 2,168,225 DMX 02/11/2002 - 53,680 02/08/2002 - 276,177 In other words, HML traded about 10x the volume on their HC news than did DMX. You can extrapolate that a HC leak would have had been of similar magnitude, and raised a few eyebrows. joe